老百姓(603883.SH):在全國化佈局方面,目前採用聚焦和下沉的戰略
格隆匯3月1日丨老百姓(603883.SH)披露機構投資者現場交流活動會議紀要(2023.2),公司表示,在全國化佈局方面,老百姓目前採用聚焦和下沉的戰略。經過二十餘年發展,公司銷售網絡已覆蓋20個省級市場,超140個地級市,全國門店數達10327家(截至2022年9月30日)。公司在前期做好廣佈局的基礎上,目前更加註重聚焦和下沉市場。目前“9+7”的聚焦戰略,是在9個優勢省份聚焦深耕,通過自建、收購、加盟、聯盟共同密集布點,7省輕資產加盟、聯盟模式為主,利用好現有自營網絡大力發展O2O線上業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.